Fulgent Genetics, Inc.

FLGT· NASDAQ· Health Care· Health Care Equipment & Services

$21.69-0.73%

2026-09-18

Financials

Valuation Metrics

Fulgent Genetics, Inc.'s Market Cap is $597M. At end of 2025 it was $809M. Ranked #2726 of 3,121 in US market (top 87%), #1178 of 1,463 on NASDAQ (top 81%), #167 of 205 in Health Care Equipment & Services (top 81%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$597M	US#2,726/3,121 Sec#167/205
Revenue	$324M	US#2,426/3,121 Sec#154/205
Net Income	$-84M	US—/3,121 Sec—/205
Total Assets	$1.09B	US#2,442/3,121 Sec#126/205
Net Assets	$1.00B	US#1,769/3,121 Sec#94/205
Value
P/B	0.60x	US#108/3,121 Sec#6/205
P/S	1.84x	US#1,230/3,121 Sec#82/205
FCF Yield	-17.39%	US—/3,121 Sec—/205
Profitability
ROE	-8.42%	US#2,340/3,121 Sec#132/205
ROA	-7.75%	US#2,613/3,121 Sec#150/205
Op. Margin	-37.08%	US#2,662/3,121 Sec#174/205
Revenue Growth	6.83%	US#1,609/3,121 Sec#115/205
Financial Health
Debt Ratio	9.31%	US#103/3,121 Sec#5/205
Total Debt	$9M	US#2,841/3,121 Sec#187/205
FCF	$-104M	US#2,636/3,121 Sec#189/205
Cash	$26M	US#2,799/3,121 Sec#183/205
Current Ratio	6.34x	US#382/3,121 Sec#27/205
Performance
1Y Return	-3.56%	US#1,841/3,121 Sec#130/205
1M Return	9.88%	US#115/3,121 Sec#19/205
From 52W High	-30.12%	US#2,044/3,121 Sec#140/205
1Y MDD	-55.30%	US#2,644/3,121 Sec#158/205
Trading
Volume	580,677 shares	US#2,386/3,121 Sec#166/205
Trading Value	$13M	US#2,545/3,121 Sec#166/205
Per Share
EPS	$-3.07	US—/3,121 Sec—/205
BPS	$36.40	US#715/3,121 Sec#47/205